Search
Menu
Meadowlark Optics - SEE WHAT

Level of tumor brightness predicts cervical cancer survival

Facebook X LinkedIn Email
Patient age at diagnosis, tumor volume and stage, and histology are the usual factors that are used to predict survival from cervical cancer. However, researchers from Washington University School of Medicine in St. Louis have discovered that these characteristics seem to have less association with prognosis and outcome than does the level of brightness detected from a glucose tracer in a PET scan. As reported in the Oct. 15 issue of Cancer, Dr. Elizabeth A. Kidd and her colleagues used PET to evaluate the amount of cervical tumor uptake of F-18 fluorodeoxyglucose (FDG) — a radiolabeled...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: December 2007
    Biophotonicscervical cancerFrom The ClinicPET scanradiation therapy

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.